We explain, via videos of true stories, the social impact of our business, our milestones and updates, and the latest news from the sectors where we operate.
The Catalan Institute of Bioengineering, the Barcelona Institute of Global Health and Bioibérica have joined forces to study the development of new compounds derived from heparin to fight malaria, a disease that infects 200 million people each year and causes half a million deaths.
Are Bioiberica biostimulants effective? How do they affect crop development and nutrition? We invite you to watch a fast-frame video on how the roots of a plant treated with one of our products grows in two months.
Professor Hemker has published over 400 research papers on Haemostasis and Thrombosis and has also dedicated his professional life to studying the action of heparin in the treatment of this disease. In this story he shows a more personal side...
It is estimated that one or two women in a thousand may have thrombosis during pregnancy. In fact, gestation increases the risk of thrombosis 3 to 6 times compared to the situation of non-pregnancy.
Late September 2016, leading glycosaminoglycan specialists convened to discuss the future of Heparin at the Institute Ronzoni Symposium, and we had the opportunity to talk to some of them. At this interview, Mr.